Home > Journals > Minerva Urology and Nephrology > Past Issues > Minerva Urology and Nephrology 2022 August;74(4) > Minerva Urology and Nephrology 2022 August;74(4):488-91



Publishing options
To subscribe
Submit an article
Recommend to your librarian


Publication history
Cite this article as


EDITORIAL COMMENT   Free accessfree

Minerva Urology and Nephrology 2022 August;74(4):488-91

DOI: 10.23736/S2724-6051.22.05017-0


language: English

Oncological safety of partial nephrectomy for pT3a renal cell carcinoma: reading between the lines

Riccardo CAMPI 1, 2 , Pietro DIANA 3, 4, Stijn MUSELAERS 5, Selçuk ERDEM 6, Michele MARCHIONI 7, 8, Alexandre INGELS 9, 10, Önder KARA 11, Umberto CARBONARA 12, Nicola PAVAN 13, Laura MARANDINO 14, Eduard ROUSSEL 15, Riccardo BERTOLO 16, on behalf of the EAU Young Academic Urologists (YAU) Renal Cancer Working Group

1 Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy; 2 Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; 3 Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain; 4 Department of Urology, IRCCS Humanitas Clinic, Rozzano, Milan, Italy; 5 Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands; 6 Division of Urologic Oncology, Department of Urology, Faculty of Medicine, Istanbul University, Istanbul, Turkey; 7 Department of Medical, Oral and Biotechnological Sciences, Laboratory of Biostatistics, G. D’Annunzio University, Chieti, Italy; 8 Department of Urology, SS Annunziata Hospital, D’Annunzio University of Chieti-Pescara, Chieti, Italy; 9 Department of Urology, Henri Mondor University Hospital, APHP, Créteil, France; 10 Biomaps, UMR1281, INSERM, CNRS, CEA, Université Paris Saclay, Villejuif, France; 11 Department of Urology, Kocaeli University School of Medicine, Kocaeli, Turkey; 12 Unit of Andrology and Kidney Transplantation, Department of Emergency and Organ Transplantation-Urology, University of Bari, Bari, Italy; 13 Department of Medical, Surgical and Health Science, Clinic of Urology, University of Trieste, Trieste, Italy; 14 Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy; 15 Department of Urology, University Hospitals of Leuven, Leuven, Belgium; 16 Department of Urology, San Carlo Di Nancy Hospital, Rome, Italy

top of page